DGFT’s extension of PSIAs validity to ease pharma foreign trade concerns in Red Sea region

In a move aimed at ensuring the stability and efficiency of pharma foreign trade operations, the Directorate General of Foreign Trade (DGFT) has extended the recognition of Pre-Shipment Inspection Agencies (PSIAs) in response to the heightened geopolitical tensions and recognizing the crucial role of the Red Sea region in international trade.

This crucial decision communicated through Public Notice No. 37/2023-DGFT comes against the backdrop of escalating geopolitical tensions affecting trade routes in the Red Sea region. The extension is specifically applicable to PSIAs completing their original three-year tenure as of December 27, 2023, effectively pushing the validity up to March 31, 2024.

The Red Sea region is of paramount importance in global trade, serving as a vital maritime corridor connecting Europe, the Middle East, and Asia. The DGFT’s move considers the heightened sensitivities in this geopolitical hotspot, aiming to ease concerns and maintain the integrity of trade practices.

In a detailed analysis of the Public Notice, it becomes evident that the extension serves as a pragmatic response to the challenges posed by geopolitical tensions. By allowing PSIAs to continue their operations smoothly, the DGFT ensures the uninterrupted flow of pre-shipment inspections, a critical aspect of international trade transactions.

The effects of this decision are not confined to India alone; it has global implications. As the Red Sea region remains a key trade route, disruptions in this area could reverberate throughout the international trade network. DGFT’s forward-looking decision mitigates potential disruptions and showcases India’s commitment to fostering stable and efficient global pharma trade practices.

“The extension from December 27, 2023, to March 31, 2024, provides relief to the listed PSIAs and businesses relying on their services, aligning with the overarching goal of promoting hassle-free foreign trade. DGFT’s role as the regulatory authority is particularly crucial in safeguarding the interests of businesses navigating the challenges posed by geopolitical tensions,” according to an international trade expert.

According to an official, “This extension is not merely a bureaucratic procedure but a strategic move by the government to support businesses and maintain the integrity of pre-shipment inspection processes. It underscores India’s commitment to facilitating a conducive environment for foreign trade amid dynamic and challenging global scenarios, especially in regions as geopolitically sensitive as the Red Sea. Businesses navigating the complexities of international trade will benefit from this extension, fostering smoother transactions until March 31, 2024”.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit